Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

As Google looks to maintain pace in AI with the rest of the tech giants, it’s consolidating its AI research divisions. Today Google announced Google DeepMind, a new unit made up of the DeepMind ...

Google Research and DeepMind have launched an AI-based healthcare platform called MedPaLM, as reported by Interesting Engineering. MedPaLM is a promising language model in the medical field so far.

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...

Google is also moving its Responsible AI teams from Research to DeepMind to "be closer to where the models are built and scaled." It also moved other responsibility teams into its central Trust ...

In the years leading up to today’s merger, DeepMind and Google Brain both made major contributions to AI research. They developed a number of groundbreaking neural networks models that unlocked ...

DeepMind’s NHS research contracts also transferring to Google Health suggests the tech giants wants zero separation between core AI health research and the means of application, using its own ...

Google has announced the consolidation of its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind. The new team will spearhead groundbreaking ...